Open AccessOne-year follow-up outcomes of treatment of wet age-related macular degeneration with aflibercept
Author(s) -
Yun Min Klimešová,
Martin Penčák,
Zbyněk Straňák,
Lucie Lalinská
Publication year - 2018
Publication title -
czech and slovak ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.178
H-Index - 11
eISSN - 1805-4447
pISSN - 1211-9059
DOI - 10.31348/2018/1/1-2-2018
Subject(s) - aflibercept , medicine , macular degeneration , ophthalmology , visual acuity , diabetic retinopathy , retrospective cohort study , cohort , retinal , optometry , surgery , diabetes mellitus , bevacizumab , chemotherapy , endocrinology
To evaluate one-year follow-up outcomes of treatment with aflibercept in patients with newly diagnosed wet age-related macular degeneration (ARMD).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom